MINIMALLY INVASIVE SURGERY OPTIONS DRIVE SURGICAL PROCEDURE VOLUMES

In the last 10 years there has been a global shift towards the use of minimally invasive surgery in place of traditional open surgical procedures

March 14, 2006—In the last 10 years there has been a global shift towards the use of minimally invasive surgery in place of traditional open surgical procedures. This trend is especially evident in cardiovascular, endoscopy, gynecology, general surgery, orthopedic, and urology procedures. The move to minimally invasive surgery is providing benefits not only to the patient, but also to the physician and hospital. These procedures offer shorter preparation, operation, and recovery time and reduce the risk of complications that can arise from open surgery. Consequently, physicians are able to perform a higher volume of procedures and patients are able to return sooner to their normal routines.

The adoption of minimally invasive procedures is particularly significant in the field of cardiovascular surgery. While the use of stents for peripheral vascular indications as a whole is growing at 10.3%, one subsegment of this procedure—the use of stents for carotid indications—will grow at more than double that rate over the forecast period. This strong growth is attributed to promising clinical trials, approval from the Food and Drug Administration, and the recent authorization of stents for carotid indications granted by Centers for Medicare and Medicaid Services.

Another noteworthy area of growth in the field of orthopedics is Kyphoplasty, which is a minimally invasive treatment of vertebral compression fractures. In the US, over the next 5 years there will be growth of 2.3% in overall spinal fusion procedures, but growth of almost 21% in Kyphoplasty procedures. The popularity of Kyphoplasty is largely attributed to its ability to reduce pain and minimize the long recovery time that is a hallmark of traditional spinal fusions.

The shift to minimally invasive surgery is also reflected throughout European and Japanese markets. Kyphoplasty, however, is awaiting regulatory approval and is not expected to enter the market until 2010. MRG’s Global Surgical Procedure Volumes 2006 discusses minimally invasive surgery as well as other traditional techniques. It covers over 100 different procedures including anesthetic, cardiovascular, dental, diagnostic imaging, endoscopy, general surgery, gynecology, neurosurgery, ophthalmology, orthopedics, urology, and varicose vein markets.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

###

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

 


For more information, contact:


Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com
Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net





Search Products

Decision Resources Group brands include: